ArticleBMJ (Clinical research ed.)2006
Extensively drug resistant tuberculosis: beware patients lost to follow-up.
Article in BMJ (Clinical research ed.), 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Joint spatiotemporal modelling of tuberculosis and human immunodeficiency virus in Ethiopia using a Bayesian hierarchical approach.BMC public health · 2025Article
- Initial second-line drug resistance ofJournal of clinical tuberculosis and other mycobacterial diseases · 2017Article
- New Conjugates of Quinoxaline as Potent Antitubercular and Antibacterial Agents.International journal of medicinal chemistry · 2016Article
- Design, synthesis and antitubercular activity of certain nicotinic Acid hydrazides.Molecules (Basel, Switzerland) · 2015Article
- Synthesis, biological evaluation and 2D-QSAR study of halophenyl bis-hydrazones as antimicrobial and antitubercular agents.International journal of molecular sciences · 2015Article
- Clonal expansion of multidrug-resistant and extensively drug-resistant tuberculosis, Japan.Emerging infectious diseases · 2010Article
- The emergence of extensively drug-resistant tuberculosis: a global health crisis requiring new interventions: part I: the origins and nature of the problem.Clinical and translational science · 2008Review
- In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxide.The Journal of antimicrobial chemotherapy · 2008Article
- Efficacy of quinoxaline-2-carboxylate 1,4-di-N-oxide derivatives in experimental tuberculosis.Antimicrobial agents and chemotherapy · 2008Article
- The emergence of extensively drug-resistant tuberculosis (TB): TB/HIV coinfection, multidrug-resistant TB and the resulting public health threat from extensively drug-resistant TB, globally and in Canada.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2007Article
- Extensively drug-resistant tuberculosis (XDR-TB) - a potential threat in Ireland.The open respiratory medicine journal · 2007Article
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.